Yassine HN - Search Results

1

Posttranslational modifications of apolipoprotein A-II proteoforms in type 2 diabetes.

Azizkhanian I, Trenchevska O, Bashawri Y, Hu J, Koska J, Reaven PD, Nelson RW, Nedelkov D, Yassine HN. Azizkhanian I, et al. Among authors: yassine hn. J Clin Lipidol. 2016 Jul-Aug;10(4):808-815. doi: 10.1016/j.jacl.2016.03.001. Epub 2016 Mar 8. J Clin Lipidol. 2016. PMID: 27578111 Free PMC article.

2

Mass spectrometric immunoassay and MRM as targeted MS-based quantitative approaches in biomarker development: potential applications to cardiovascular disease and diabetes.

Yassine H, Borges CR, Schaab MR, Billheimer D, Stump C, Reaven P, Lau SS, Nelson R. Yassine H, et al. Proteomics Clin Appl. 2013 Aug;7(7-8):528-40. doi: 10.1002/prca.201200028. Epub 2013 Jul 9. Proteomics Clin Appl. 2013. PMID: 23696124 Free PMC article. Review.

3

The application of multiple reaction monitoring and multi-analyte profiling to HDL proteins.

Yassine HN, Jackson AM, Borges CR, Billheimer D, Koh H, Smith D, Reaven P, Lau SS, Borchers CH. Yassine HN, et al. Lipids Health Dis. 2014 Jan 8;13:8. doi: 10.1186/1476-511X-13-8. Lipids Health Dis. 2014. PMID: 24397693 Free PMC article.

4

Enhanced cholesterol efflux to HDL through the ABCA1 transporter in hypertriglyceridemia of type 2 diabetes.

Yassine HN, Belopolskaya A, Schall C, Stump CS, Lau SS, Reaven PD. Yassine HN, et al. Metabolism. 2014 May;63(5):727-34. doi: 10.1016/j.metabol.2014.03.001. Epub 2014 Mar 5. Metabolism. 2014. PMID: 24636347 Free PMC article.

5

Elevated plasma albumin and apolipoprotein A-I oxidation under suboptimal specimen storage conditions.

Borges CR, Rehder DS, Jensen S, Schaab MR, Sherma ND, Yassine H, Nikolova B, Breburda C. Borges CR, et al. Mol Cell Proteomics. 2014 Jul;13(7):1890-9. doi: 10.1074/mcp.M114.038455. Epub 2014 Apr 15. Mol Cell Proteomics. 2014. PMID: 24736286 Free PMC article.

6

Serum amyloid a truncations in type 2 diabetes mellitus.

Yassine HN, Trenchevska O, He H, Borges CR, Nedelkov D, Mack W, Kono N, Koska J, Reaven PD, Nelson RW. Yassine HN, et al. PLoS One. 2015 Jan 21;10(1):e0115320. doi: 10.1371/journal.pone.0115320. eCollection 2015. PLoS One. 2015. PMID: 25607823 Free PMC article. Clinical Trial.

7

The Application of Multiple Reaction Monitoring to Assess Apo A-I Methionine Oxidations in Diabetes and Cardiovascular Disease.

Yassine HN, Jackson AM, Reaven PD, Nedelkov D, Nelson RW, Lau SS, Borchers CH. Yassine HN, et al. Transl Proteom. 2014 Dec 1;4-5:18-24. doi: 10.1016/j.trprot.2014.10.001. Transl Proteom. 2014. PMID: 25705587 Free PMC article.

8

The Association of Human Apolipoprotein C-III Sialylation Proteoforms with Plasma Triglycerides.

Yassine HN, Trenchevska O, Ramrakhiani A, Parekh A, Koska J, Walker RW, Billheimer D, Reaven PD, Yen FT, Nelson RW, Goran MI, Nedelkov D. Yassine HN, et al. PLoS One. 2015 Dec 3;10(12):e0144138. doi: 10.1371/journal.pone.0144138. eCollection 2015. PLoS One. 2015. PMID: 26633899 Free PMC article.

9

Disialylated apolipoprotein C-III proteoform is associated with improved lipids in prediabetes and type 2 diabetes.

Koska J, Yassine H, Trenchevska O, Sinari S, Schwenke DC, Yen FT, Billheimer D, Nelson RW, Nedelkov D, Reaven PD. Koska J, et al. J Lipid Res. 2016 May;57(5):894-905. doi: 10.1194/jlr.P064816. Epub 2016 Mar 3. J Lipid Res. 2016. PMID: 26945091 Free PMC article.

10

The association of plasma cystatin C proteoforms with diabetic chronic kidney disease.

Yassine HN, Trenchevska O, Dong Z, Bashawri Y, Koska J, Reaven PD, Nelson RW, Nedelkov D. Yassine HN, et al. Proteome Sci. 2016 Mar 25;14:7. doi: 10.1186/s12953-016-0096-7. eCollection 2016. Proteome Sci. 2016. PMID: 27019641 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

86 results

Search Page

Filters